Loss of neuronal GSK3β reduces dendritic spine stability and attenuates excitatory synaptic transmission via β-catenin

Molecular Psychiatry

Volumn 20, Issue 4, 2015, Pages 482-489

  Ochs, S M ^a   Dorostkar, M M ^a   Aramuni, G ^a   Schon C ^a   Filser, S ^a   Poschl J ^a   Kremer, A ^c   Van Leuven, F ^c   Ovsepian, S V ^a   Herms, J ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Germany 3 Munich Cluster for Systems Neurology   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR AFFECTING AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BACTERIAL PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PHOTOPROTEIN; PICROTOXIN; TAMOXIFEN; YELLOW FLUORESCENT PROTEIN, BACTERIA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; CELL LOSS; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC SPINE; ELECTROPHYSIOLOGICAL PROCEDURES; EXCITATORY SYNAPTIC TRANSMISSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SYNAPTIC TRANSMISSION; ANIMAL; BRAIN CORTEX; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; IN VITRO STUDY; METABOLISM; NERVE CELL; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BACTERIAL PROTEINS; BETA CATENIN; CEREBRAL CORTEX; DENDRITIC SPINES; EXCITATORY AMINO ACID AGENTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA ANTAGONISTS; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; IN VITRO TECHNIQUES; LUMINESCENT PROTEINS; MICE; MICE, TRANSGENIC; NEURONS; PATCH-CLAMP TECHNIQUES; PICROTOXIN; TAMOXIFEN;

EID: 84926199558     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.55     Document Type: Article

References (26)

1. Budnik V, Salinas PC. Wnt signaling during synaptic development and plasticity. Curr Opin Neurobiol 2011; 21: 151-159.
2. Salinas PC, Zou Y. Wnt signaling in neural circuit assembly. Annu Rev Neurosci 2008; 31: 339-358.
3. Salinas PC, Hall AC. Lithium and synaptic plasticity. Bipolar Disord 1999; 1: 87-90.
4. Salcedo-Tello P, Ortiz-Matamoros A, Arias C. GSK3 Function in the brain during development, neuronal plasticity, and neurodegeneration. Int J Alzheimers Dis 2011; 2011: 189728.
5. Sutherland C, Leighton IA, Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 1993; 296: 15-19.
6. Sutherland C. What are the bona fide GSK3 Substrates? Int J Alzheimers Dis 2011; 2011: 505607.
7. Beaulieu J-M, Gainetdinov RR, Caron MG. Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 2009; 49: 327-347.
8. Dewachter I, Ris L, Jaworski T, Seymour CM, Kremer A, Borghgraef P et al. GSK3beta, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9. Neurobiol Dis 2009; 35: 193-200.
9. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J et al. LTP Inhibits LTD in the hippocampus via regulation of GSK3[beta]. Neuron 2007; 53: 703-717.
10. Collingridge GL, Peineau S, Howland JG, Wang YT. Long-term depression in the CNS. Nat Rev Neurosci 2010; 11: 459-473.
11. Fu M, Zuo Y. Experience-dependent structural plasticity in the cortex. Trends Neurosci 2011; 34: 177-187.
12. Fiala JC, Spacek J, Harris KM. Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Rev 2002; 39: 29-54.
13. Penzes P, Cahill ME, Jones KA, VanLeeuwen J-E, Woolfrey KM. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 2011; 14: 285-293.
14. Young P, Qiu L, Wang D, Zhao S, Gross J, Feng G. Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice. Nat Neurosci 2008; 11: 721-728.
15. Jaworski T, Dewachter I, Lechat B, Gees M, Kremer A, Demedts D et al. GSK-3α/β kinases and amyloid production in vivo. Nature 2011; 480: E4-E5.
16. Harada N, Tamai Y, Ishikawa T-o, Sauer B, Takaku K, Oshima M et al. Intestinal polyposis in mice with a dominant stable mutation of the [beta]-β-catenin gene. EMBO J 1999; 18: 5931-5942.
17. Harris K, Jensen F, Tsao B. Three-dimensional structure of dendritic spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages: implications for the maturation of synaptic physiology and long-term potentiation [published erratum appears in J Neurosci 1992 Aug;12(8):following table of contents]. Journal Neurosci 1992; 12: 2685-2705.
18. Gould TD, Einat H, Bhat R, Manji HK. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 2004; 7: 387-390.
19. Peters A, Kaiserman-Abramof IR. The small pyramidal neuron of the rat cerebral cortex. The perikaryon, dendrites and spines. Am J Anat 1970; 127: 321-355.
20. Hayashi Y, Majewska AK. Dendritic spine geometry: functional implication and regulation. Neuron 2005; 46: 529-532.
21. Holtmaat AJGD, Trachtenberg JT, Wilbrecht L, Shepherd GM, Zhang X, Knott GW et al. Transient and persistent dendritic spines in the neocortex in vivo. Neuron 2005; 45: 279-291.
22. Auger C, Kondo S, Marty A. Multivesicular release at single functional synaptic sites in cerebellar stellate and basket cells. J Neurosci 1998; 18: 4532-4547.
23. Lisman JE, Raghavachari S, Tsien RW. The sequence of events that underlie quantal transmission at central glutamatergic synapses. Nat Rev Neurosci 2007; 8: 597-609.
24. Raghavachari S, Lisman JE. Properties of quantal transmission at CA1 synapses. J Neurophysiol 2004; 92: 2456-2467.
25. Maguschak KA, Ressler KJ. The dynamic role of beta-β-catenin in synaptic plasticity. Neuropharmacology 2012; 62: 78-88.
26. Mines MA, Jope RS. Glycogen synthase kinase-3: a promising therapeutic target for fragile X syndrome. Front Mol Neurosci 2011; 4: 35.